AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PARADIGM BIOPHARMACEUTICALS

0.255

+0.0052.00%

Volume:1.38M

Turnover:348.34K

Market Cap:154.75M

PE:-1.68

High:0.260

Open:0.250

Low:0.245

Close:0.250

52wk High:0.470

52wk Low:0.135

Shares:606.85M

Float Shares:353.07M

Volume Ratio:0.51

T/O Rate:0.39%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.152

EPS(LYR):-0.152

ROE:-456.96%

ROA:-138.75%

PB:44.59

PE(LYR):-1.68

Loading ...

Overview Company News Filings

Company Profile

Company Name:

PARADIGM BIOPHARMACEUTICALS

Exchange:

ASX

Establishment Date:

2014

Employees:

- -

Office Location:

500 Collins Street,Level 15,Melbourne,Victoria,Australia

Website:

http://www.paradigmbiopharma.com

Zip Code:

3000

Phone:

Fax:

61 3 9629 5466

Introduction:

Paradigm Biopharmaceuticals Limited, a biopharmaceutical company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulphate sodium drugs in the injectable and tablet forms for the treatment of bone marrow edema, respiratory, and alphaviral arthritis diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/PAR.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"PAR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAR.AU\",,,,,undefined,":{"symbol":"PAR.AU","market":"AU","secType":"STK","nameCN":"PARADIGM BIOPHARMACEUTICALS","latestPrice":0.255,"timestamp":1789531160241,"preClose":0.25,"halted":0,"volume":1378382,"delay":0,"changeRate":0.020000000000000018,"nameEN":"PARADIGM BIOPHARMACEUTICALS","floatShares":353065639,"shares":606848701,"eps":-0.152232,"marketStatus":"Trading","change":0.005,"latestTime":"09-16 14:03:20 AEST","open":0.25,"high":0.26,"low":0.245,"amount":348336,"amplitude":0.06,"askPrice":0.255,"askSize":56482,"bidPrice":0.25,"bidSize":70773,"shortable":3,"etf":0,"ttmEps":-0.152232,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789538400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.25,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":0.51138,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"PAR.AU","preClose":0.25,"auctionPrice":0.25,"auctionVolume":114411,"auctionTime":1789516750297,"referenceTime":1789468203091,"auction":1,"marketStatus":"盘前竞价","timestamp":1789516750297}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAR.AU\",,,,,undefined,":{"symbol":"PAR.AU","floatShares":353065639,"roa":"-138.75%","roe":"-456.96%","lyrEps":-0.152232,"volumeRatio":0.51138,"shares":606848701,"dividePrice":0,"high":0.26,"amplitude":0.06,"preClose":0.25,"low":0.245,"week52Low":0.135,"pbRate":"44.59","psRate":"18313.19","week52High":0.47,"institutionHeld":0,"latestPrice":0.255,"committee":0.112302,"eps":-0.152232,"divideRate":0,"volume":1378382,"delay":0,"ttmEps":-0.152232,"open":0.25,"prevYearClose":0.34,"prevWeekClose":0.24,"prevMonthClose":0.225,"prevQuarterClose":0.165,"fiveDayClose":0.27,"twentyDayClose":0.17,"sixtyDayClose":0.17,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PAR.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-02-06","symbol":"PAR.AU","defaultRemindTime":1738796400000,"type":"split","dateTimestamp":1738760400000,"forFactor":4,"toFactor":5,"ratio":0.8},{"market":"AU","date":"2022-08-17","symbol":"PAR.AU","defaultRemindTime":1660694400000,"type":"split","dateTimestamp":1660658400000,"forFactor":992772,"toFactor":1000000,"ratio":0.992772}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PAR.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":276414891,"yearFounded":2014,"address":"500 Collins Street,Level 15,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9629 5566","officeFax":"61 3 9629 5466","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://www.paradigmbiopharma.com","stockEarnings":[{"period":"1week","weight":-0.0909},{"period":"1month","weight":0.3889},{"period":"3month","weight":0.3889},{"period":"6month","weight":-0.0385},{"period":"1year","weight":-0.0741},{"period":"ytd","weight":-0.2647}],"compareEarnings":[{"period":"1week","weight":-0.0053},{"period":"1month","weight":-0.0182},{"period":"3month","weight":0.0233},{"period":"6month","weight":0.0685},{"period":"1year","weight":0.0981},{"period":"ytd","weight":0.0357}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Paradigm Biopharmaceuticals Limited, a biopharmaceutical company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulphate sodium drugs in the injectable and tablet forms for the treatment of bone marrow edema, respiratory, and alphaviral arthritis diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.272727,"avgChangeRate":-0.078902},{"month":2,"riseRate":0.454545,"avgChangeRate":0.019659},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.033069},{"month":4,"riseRate":0.454545,"avgChangeRate":0.070789},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.031471},{"month":6,"riseRate":0.545455,"avgChangeRate":0.061432},{"month":7,"riseRate":0.454545,"avgChangeRate":0.002671},{"month":8,"riseRate":0.583333,"avgChangeRate":0.11225},{"month":9,"riseRate":0.545455,"avgChangeRate":0.040273},{"month":10,"riseRate":0.545455,"avgChangeRate":0.131474},{"month":11,"riseRate":0.181818,"avgChangeRate":-0.081789},{"month":12,"riseRate":0.454545,"avgChangeRate":0.065089}],"exchange":"ASX","name":"PARADIGM BIOPHARMACEUTICALS","nameEN":"PARADIGM BIOPHARMACEUTICALS"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PAR.AU\",market:\"AU\",,,undefined,":null}}